Portfolio company
HotSpot Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops allosteric small molecule medicines for patients with cancer and autoimmune diseases by targeting natural regulatory pockets on proteins.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BlossomHill Therapeutics
This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.
Matchpoint Therapeutics
This biotechnology company develops oral covalent small molecule medicines to treat patients with autoimmune and inflammatory diseases.
Biopharmaceutical company
This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.
Allorion Therapeutics
This biopharmaceutical company develops small-molecule therapies for cancer and autoimmune diseases to serve patients and global pharmaceutical partners.
Atavistik Bio
This biotechnology company develops oral allosteric small molecule therapeutics for patients with rare hematological diseases and cancers.
Allorion
This biotechnology company develops small-molecule drugs for patients with cancer and autoimmune diseases using its proprietary drug discovery platforms.
Biotheryx
The company develops protein degrader medicines for patients with cancer and inflammatory diseases.
Auron Therapeutics
This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.
